Citius Oncology (CTOR) Institutional Ownership $1.19 -0.01 (-0.83%) As of 11:11 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Citius Oncology (NASDAQ:CTOR)CurrentInstitutional OwnershipPercentage70.52%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$16.19KNumber ofInstitutional Sellers(last 12 months)0 Get CTOR Insider Trade Alerts Want to know when executives and insiders are buying or selling Citius Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Citius Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/4/2025 IFP Advisors Inc22,215$26K0.0%+173.1%0.031% (Data available from 1/1/2016 forward) CTOR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CTOR shares? During the previous two years, the following institutional investors and hedge funds held shares of Citius Oncology shares: IFP Advisors Inc ($26K).Learn more on CTOR's institutional investors. What percentage of Citius Oncology stock is owned by institutional investors? 70.52% of Citius Oncology stock is owned by institutional investors. Learn more on CTOR's institutional investor holdings. Which institutional investors have been buying Citius Oncology stock? The following institutional investors have purchased Citius Oncology stock in the last 24 months: IFP Advisors Inc ($14.08K). How much institutional buying is happening at Citius Oncology? Institutional investors have bought a total of 14,080 shares in the last 24 months. This purchase volume represents approximately $16.19K in transactions. Related Companies Corvus Pharmaceuticals Institutional Ownership Trevi Therapeutics Institutional Ownership Korro Bio Institutional Ownership Tango Therapeutics Institutional Ownership Atai Life Sciences Institutional Ownership Taysha Gene Therapies Institutional Ownership Kodiak Sciences Institutional Ownership Atyr PHARMA Institutional Ownership Rezolute Institutional Ownership Neumora Therapeutics Institutional Ownership This page (NASDAQ:CTOR) was last updated on 2/11/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredElon’s Chosen OnesMillions of Federal employees just got put on notice... In a single sweeping move, President Trump just off...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
